← Back to patent-cliff list
BBP-418
Tier C — Watch / tradeBBP-418
Atrium Health
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Indications (approved)：肢带型肌营养不良2I型, 肢带型肌营养不良2A型
Regional status
US
Phase III
2023-05-31
EU
Phase III
2023-05-31
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of BBP-418?
Approved indications include: 肢带型肌营养不良2I型, 肢带型肌营养不良2A型.
When does the BBP-418 patent expire?
No public expiry year is available for BBP-418 yet; this page updates once verified.
How do I get a quote for BBP-418 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03